A new global prostatecancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co. (MSD) has just been launched in the US and Canada: ‘Never Miss ...
The campaign goes from September through November, with Depend writing on its website the company’s goal is to raise $300,000 to donate to the ProstateCancer Foundation. Another famous figure ...
The moves follow the Daily Mail's Dying of Embarrassment campaign, which saw readers ... be invited to have a check to see if they have prostatecancer. They will then be whittled down to around ...
and Movember is excited to be kicking off its 21st campaign to help shine a light on some of the most pressing health issues facing men today - mental health, suicide prevention, prostatecancer ...
Some results have been hidden because they may be inaccessible to you